National reports-Recently approved legislation to boost insurance coverage of care for mental health disorders could have just the opposite effect, according to insurers.
NATIONAL REPORTS-Recently approved legislation to boost insurance coverage of care for mental health disorders could have just the opposite effect, according to insurers.
The bill adopted last month by the House requires employer-sponsored insurance that covers mental-health services to provide the same level of coverage as for medical benefits. More specifically, most group plans could not have higher copays or stricter coverage limits for mental conditions. The measure also requires coverage of a broad range of conditions that fall under the mental health umbrella, including substance abuse.
The House bill was sponsored by Reps. Patrick Kennedy (D-R.I.), who has battled depression, alcoholism and drug abuse, and Jim Ramstad (R-Minn.), a recovering alcoholic who is Rep. Kennedy's Alcoholics Anonymous sponsor.
The bill is projected to raise public and private outlays by $4.3 billion over 10 years. To offset that amount, the legislation proposes to gain $2.4 billion by restricting activities of physician-owned specialty hospitals. Another $2 billion would come from a significant increase in rebates on prescription drugs paid by manufacturers to state Medicaid programs.
Health insurers are looking to the Senate to modify the House policy. The Senate approved a much narrower version of mental health parity legislation last fall that provides insurers and payers more flexibility and carries no cost offsets.
QUESTIONABLE COVERAGE?
According to the Associated Press, the House measure specifies that if a plan provides mental health benefits, it must cover mental illnesses and addiction disorders that are listed in the American Psychiatric Assn.'s Diagnostic and Statistical Manual of Mental Disorders, which is used by mental health professionals.
Rep. Phil Gingrey, MD (R-Ga.), complained that the House bill would mandate coverage for conditions such as jet lag and sexual dysfunction, which are listed in the psychiatric association's manual. "Can you imagine any employer being willing to cover things like that?" Dr. Gingrey asks.
Patient advocates have been pressing for years for legislation to boost mental health benefits, but the wide differences between the two measures may make compromise difficult.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More